戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 e incorporation increases resistance against snake venom phosphodiesterase.
2 i Klenow fragment (KF) 3'-5' exonuclease and snake venom phosphodiesterase.
3 re very resistant to enzymatic hydrolysis by snake venom phosphodiesterase.
4 d calf spleen phosphodiesterase, but not for snake venom phosphodiesterase.
5 ine phosphatase and sensitive to cleavage by snake venom phosphodiesterase.
6 y (ESI-MS), and is resistant to digestion by snake venom phosphodiesterase.
7           Second, treatment of polymers with snake venom phosphodiesterase and alkaline phosphatase y
8 sed from DNA by hydrolysis with nuclease P1, snake venom phosphodiesterase and alkaline phosphatase.
9 its 2'-deoxyribonucleosides upon exposure to snake venom phosphodiesterase and bacterial alkaline pho
10  enzyme activity such as that represented by snake venom phosphodiesterase and by that found in human
11 analogues were stable toward hydrolysis with snake venom phosphodiesterase and stimulated RNase H1 ac
12  highly resistant to enzymatic hydrolysis by snake venom phosphodiesterase and they are 4-5 times mor
13 tion was monitored in an in vitro assay with snake venom phosphodiesterase as the hydrolytic enzyme.
14 -3'dN) were corroborated by a combination of snake venom phosphodiesterase digestion in the presence
15 equence can be generated in conjunction with snake venom phosphodiesterase digestion of purified mate
16 to be completely resistant to degradation by snake venom phosphodiesterase, DNase I and HeLa cell nuc
17  (ODN) with snake venom phosphodiesterase or snake venom phosphodiesterase/DNase I was used to measur
18 re, we outline the steps necessary to purify snake venom phosphodiesterase I (SVP) and describe two a
19 ssessing phosphodiesterase activity, such as snake venom phosphodiesterase, mammalian ectonucleotide
20 DP saccharides based on their degradation by snake venom phosphodiesterase or hyaluronidase and by th
21 clease resistance of the oligonucleotides to snake venom phosphodiesterase or intracellular nucleases
22 le-stranded oligodeoxynucleotides (ODN) with snake venom phosphodiesterase or snake venom phosphodies
23                   Enhanced stability against snake venom phosphodiesterase resulted from modification
24  exhibit moderately higher stability against snake venom phosphodiesterase, S1 nuclease and in fetal
25  understanding of critical factors affecting snake venom phosphodiesterase (SVP) digestion of such OD
26  The exonuclease digestion rate, with either snake venom phosphodiesterase (SVP) or bovine spleen pho
27 ied oligodeoxynucleotides was examined using snake venom phosphodiesterase (SVPD) and nuclease S1.
28 of protocols incorporating an exonucleolytic snake venom phosphodiesterase (SVPD) digestion stage to
29 in the presence of 3'-specific exonucleases, snake venom phosphodiesterase (SVPD), demonstrated signi
30 gnificantly more stable against digestion by snake venom phosphodiesterases (SVPD) as compared to unm
31 ty of O(6)-POB-dG to hinder DNA digestion by snake venom phosphodiesterase (SVPDE), a 3'-exonuclease
32 he conserved minor venom components, such as snake venom phosphodiesterase (svPDE), remain largely un
33      The adenylyl group can be hydrolyzed by snake venom phosphodiesterase to afford the unmodified e
34 s method, alkaline phosphatase is added with snake venom phosphodiesterase to the oligonucleotide sol
35 phoramidates are resistant to digestion with snake venom phosphodiesterase, to nuclease activity in a